Artificial Intelligence in Healthcare Diagnosis Global Market Report 2024

The artificial intelligence in healthcare diagnosis market size has grown exponentially in recent years. It will grow from $16.28 billion in 2023 to $23.58 billion in 2024 at a compound annual growth rate (CAGR) of 44.9%. The growth in the historical period can be attributed to progress in medical imaging, increased accessibility and digitization of data, optimization of clinical workflows, investments in research and development, and a shortage of healthcare professionals.

The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $104.32 billion in 2028 at a compound annual growth rate (CAGR) of 45.0%. The anticipated growth in the forecast period can be ascribed to AI-powered precision medicine, integration with electronic health records, the expansion of medical imaging analysis, the rise of wearable health tech, and regulatory support and standards. Major trends in the forecast period encompass explainable AI in healthcare, AI-driven early disease detection, telehealth integration, AI in pathology and histopathology, and AI-enabled point-of-care diagnostics.

The anticipated growth in the artificial intelligence (AI) in healthcare diagnosis market is driven by the increasing incidence rate of chronic diseases. Chronic diseases, characterized by their long-term progression and intermittent persistence, are expected to benefit from the transformative impact of AI in healthcare diagnosis. This technology holds the potential for significant improvements in disease management, diagnosis, and resource utilization, leading to cost savings. AI can empower medical practitioners to enhance decision-making, identify patients at risk, and deliver more personalized care. For example, in September 2022, the World Health Organization reported 41 million deaths annually, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases globally. These included 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the rising incidence of chronic diseases is a key driver of the growth in the artificial intelligence in the healthcare diagnosis market.

The expanding adoption of telemedicine is expected to contribute to the growth of artificial intelligence in the healthcare diagnosis market. Telemedicine, involving the use of telecommunications technology for remote medical care, has surged in popularity, increasing the demand for AI in healthcare diagnosis. AI tools play a crucial role in supporting healthcare providers by enabling remote diagnoses based on patient-reported symptoms and data. For instance, a report from the American Psychological Association in January 2022 indicated that the percentage of clinicians utilizing telehealth with at least some of their patients increased from 33% in 2020 to 50% in 2021. Consequently, the increasing prevalence of telemedicine is fostering the growth of artificial intelligence in the healthcare diagnosis market.


Technological advancement stands out as a prominent trend gaining traction in the artificial intelligence in the healthcare diagnosis market. Leading companies in this market are actively focusing on the development of innovative technologies to maintain their competitive edge. For instance, in March 2023, Genomic Vision, a biotechnology company based in France, unveiled FiberSmart, an AI-powered software designed to automate the detection and quantification of fluorescent signals on combed DNA (Deoxyribonucleic acid) molecules. Boasting a user-friendly interface, FiberSmart facilitates rapid analysis of DNA replication signals, extracting crucial parameters that describe replication kinetics. Employing advanced AI techniques, FiberSmart surpasses Genomic Vision's existing software solutions, offering up to three times more accurate visualization, detection, and evaluation of DNA replication kinetics, all achieved up to ten times faster. The software's ergonomic design enhances user convenience, enabling swift analysis of DNA replication signals to derive essential variables describing replication kinetics.

Major players in the artificial intelligence in the healthcare diagnosis market are directing their efforts toward the development of innovative solutions, with a focus on AI-powered disease detection. This involves leveraging artificial intelligence technologies to analyze medical data, including images, patient records, and diagnostic tests, for the identification and detection of various diseases or health conditions. For example, in May 2023, Aegis Ventures LLC, a next-generation venture studio based in the US, partnered with Northwell Holdings, a US-based medical technology company, to introduce ‘Optain’. Utilizing images of the eye captured with a simple, portable retinal camera, Optain's AI not only screens for eye-related conditions but also identifies 140 diseases throughout the body. The goal is to detect these diseases at the earliest stage when they are most treatable.

In October 2022, Beckman Coulter Diagnostics, a US-based clinical diagnostics company, completed the acquisition of StoCastic LLC for an undisclosed amount. StoCastic's TriageGo is set to become the cornerstone of Beckman Coulter's AI-powered Clinical Decision Support (CDS) portfolio. This evolving discipline aims to enhance patient care by providing physicians with data-driven insights and optimizing clinical decision-making. StoCastic LLC, an artificial intelligence company based in the US, specializes in developing AI-powered tools for healthcare providers to achieve more accurate and efficient disease diagnoses.

Major companies operating in the artificial intelligence in healthcare diagnosis market report are Johnson and Johnson Private Limited, Intel Corporation, International Business Machines Corporation, Medtronic, Nvidia Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Agfa-Gevaert Group, Google Deep Mind, Babylon Health, HeartFlow Inc., Corti HQ, Aidoc, Aidoc Medical Ltd., Imagen Technologies, AliveCor Inc., Digital Diagnostics Inc., Enlitic Inc., NovaSignal Corp., Cleerly Inc., Butterfly Network Inc., IBM Watson Health, Arterys Inc., Caption Health, Zebra Medical Vision Inc., Vuno Inc., Riverain Technologies, CloudMedX Inc., Neural Analytics Inc.

North America was the largest region in the artificial intelligence in healthcare diagnosis market in 2023. The regions covered in the artificial intelligence in healthcare diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence in healthcare diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary components incorporated in artificial intelligence in healthcare diagnosis consist of software, services, and hardware. Software is a compilation of programs, data, and instructions designed to execute specific tasks on a computer or electronic device. These components are utilized across various medical diagnoses, including cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. The modalities involved comprise MRI (magnetic resonance imaging), CT (computed tomography), X-ray, and ultrasound, catering to applications in both in vivo and in vitro diagnostics. The end-users benefiting from these AI applications include hospitals, diagnostic imaging centers, diagnostic laboratories, and others.

The artificial intelligence in healthcare diagnosis market research report is one of a series of new reports that provides artificial intelligence in healthcare diagnosis market statistics, including artificial intelligence in healthcare diagnosis industry global market size, regional shares, competitors with an artificial intelligence in healthcare diagnosis market share, detailed artificial intelligence in healthcare diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in healthcare diagnosis industry. This artificial intelligence in healthcare diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) in healthcare diagnosis market consists of revenues earned by entities by providing medical imaging analysis, genetic analysis, clinical decision support, risk prediction and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial Intelligence (AI) in the healthcare diagnosis market also includes sales of surgical robots and visual tools which are used in providing AI in healthcare diagnosis services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.